CUTANEOUS T-CELL LYMPHOMA
Clinical trials for CUTANEOUS T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World check: does approved skin cancer drug deliver?
Disease control CompletedThis study looked at how the drug mogamulizumab performed for patients with cutaneous T-cell lymphoma (CTCL) in everyday medical practice, not just in a controlled trial. It involved 100 adults in Italy who had already tried at least one other treatment. The goal was to confirm t…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo tested in High-Stakes fight against rare blood cancers
Disease control CompletedThis study tested whether adding the drug romidepsin to a stem cell transplant could better control several aggressive types of T-cell blood cancers. Researchers gave romidepsin before and after the transplant to 23 patients to find the safest dose and see if it helped. The main …
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug cocktail tested for rare, aggressive cancers
Disease control CompletedThis early-stage study tested whether a combination of four existing drugs could be safely given to adults with rare T-cell cancers that had returned or stopped responding to standard treatments. The main goal was to find the safest dose and understand the side effects. Researche…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Light-Activated ointment targets skin cancer lesions
Disease control CompletedThis study tested a treatment for early-stage mycosis fungoides, a type of skin lymphoma. Ten participants applied a special ointment to their skin lesions, which was then activated by visible light twice a week for up to a year. The main goal was to see if this treatment could r…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Ellen Kim, MD • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC